The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
Brief Report
PreviousPrevious
Volume 340:1630-1638 May 27, 1999 Number 21
NextNext

Prion Protein Conformation in a Patient with Sporadic Fatal Insomnia
James A. Mastrianni, M.D., Ph.D., Randal Nixon, M.D., Ph.D., Robert Layzer, M.D., Glenn C. Telling, Ph.D., Dong Han, M.S., Stephen J. DeArmond, M.D., Ph.D., and Stanley B. Prusiner, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Commentary
-Editorial
 by Gambetti, P.

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
The human prion diseases include Creutzfeldt–Jakob disease, Gerstmann–Sträussler–Scheinker disease, fatal familial insomnia, and the recently described new variant of Creutzfeldt–Jakob disease. Much evidence argues that a post-translational, noncovalent modification of prion protein is the fundamental event in the mechanism underlying these diseases.1 The normal cellular isoform of the prion protein (PrPC) is predominantly {alpha}-helical, is detergent soluble, and is readily digested by proteases. In contrast, the pathogenic isoform (PrPSc) has a substantially ß-sheet structure, is insoluble in nondenaturing detergents, and shows relative resistance to proteolytic digestion.2,3,4 The protease-resistant core of PrPSc, designated PrP27–30, is usually detectable in . . . [Full Text of this Article]

Case Report

Methods

Genetic Analysis

Neuropathological Analysis

Protein Analysis

Immunoblotting and Histologic Examination of Transgenic Animals

Results

Neuropathological Findings

Genotyping

PrPSc Distribution and Conformation

Transmission Studies

Discussion


Source Information

From the Institute for Neurodegenerative Diseases, Department of Neurology (J.A.M., R.N., R.L., G.C.T., D.H., S.J.D., S.B.P.), and the Departments of Pathology (S.J.D.) and Biochemistry and Biophysics (S.B.P.), University of California, San Francisco; and the Department of Neurology, University of Chicago, Chicago (J.A.M.).

Address reprint requests to Dr. Prusiner at the Department of Neurology, Box 0518, University of California, San Francisco, CA 94143-0518.

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.